The role of GM-CSF in lung cancer: a review of the literature

This publication has 24 references indexed in Scilit:

• CODE Chemotherapy with or without Recombinant Human Granulocyte Colony-Stimulating Factor in Extensive-Stage Small Cell Lung Cancer
  Oncology, 1992
• Dose intensive weekly code chemotherapy (CT) with or without recombinant human granulocyte colony-stimulating factor (rhG-CSF) in extensive-stage (ES) small cell lung cancer (SCLC): M. Fukuoka, N. Masuda, S. Negoro, M. Takada, S. Kishimoto, N. Kodama, M. Kawahara, K. Furuse. Dept. of Internal Medicine, Osaka Prefectural Habikino Hospital and National Kinki Central Hospital, Osaka, Japan
  Lung Cancer, 1991
• Granulocyte- macrophage colony stimulating factor(GMCSF) and accelerated Chemotherapy (CT) in small cell lung cancer (SCLC)
  Lung Cancer, 1991
• Hematopoietic Growth Factors
  New England Journal of Medicine, 1989
• Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation
  New England Journal of Medicine, 1988
• Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1987
• New drugs in small-cell lung cancer
  Cancer Treatment Reviews, 1986
• “Total” Therapy for Small Cell Carcinoma of the Lung
  The Annals of Thoracic Surgery, 1978
• Bacterial Stimulation and Granulocyte Inhibition of Granulopoietic Factor Production
  New England Journal of Medicine, 1977
• THE GROWTH OF MOUSE BONE MARROW CELLS IN VITRO
  Immunology & Cell Biology, 1966